How Moderna Stock Can Double From Here
If you had bought shares of Moderna (NASDAQ: MRNA) when it first went public and held those shares, you'd now be sitting on a gain of nearly 2,200%. The stock has more than quadrupled so far this year.
This jaw-dropping performance has given Moderna a market cap of more than $170 billion. Some think that the biotech doesn't deserve such a rich valuation. One analyst even predicts that Moderna's share price could plunge around 70%.
But could Moderna instead keep rising significantly higher? It's possible. Here's how Moderna stock could potentially double from here.
Source Fool.com
